Evidence map›Paper›PMID 27414521›Full record

Trial reportJournal of medicinal food2016

The Human Skeletal Muscle Transcriptome in Response to Oral Shilajit Supplementation.

Amitava Das, Soma Datta, Brian Rhea, Mithun Sinha, Muruganandam Veeraragavan, Gayle Gordillo, Sashwati Roy

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of medicinal food, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02026414 (Effects of PrimaVie and Exercise Training on Human Skeletal Muscle Adaptation), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02026414 nacompletednot on this map

Effects of PrimaVie and Exercise Training on Human Skeletal Muscle Adaptation

TypeinterventionalSponsorSanni RajuRan2014 to 2018Enrolled29ConditionsObesityArmsPrimaVie, Exercise
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Amitava Das1 Department of Surgery, Davis Heart and Lung Research Institute, Center for Regenerative Medicine and Cell-Based Therapies and Comprehensive Wound Center, The Ohio State University , Wexner Medical Center, Columbus, Ohio, USA.
Soma Datta1 Department of Surgery, Davis Heart and Lung Research Institute, Center for Regenerative Medicine and Cell-Based Therapies and Comprehensive Wound Center, The Ohio State University , Wexner Medical Center, Columbus, Ohio, USA.
Brian Rhea1 Department of Surgery, Davis Heart and Lung Research Institute, Center for Regenerative Medicine and Cell-Based Therapies and Comprehensive Wound Center, The Ohio State University , Wexner Medical Center, Columbus, Ohio, USA.
Mithun Sinha1 Department of Surgery, Davis Heart and Lung Research Institute, Center for Regenerative Medicine and Cell-Based Therapies and Comprehensive Wound Center, The Ohio State University , Wexner Medical Center, Columbus, Ohio, USA.
Muruganandam Veeraragavan2 Research and Development, Natreon India , Rishi Tech Park, New Town, Kolkata, India .
Gayle Gordillo3 Department of Plastic Surgery, Davis Heart and Lung Research Institute, Center for Regenerative Medicine and Cell-Based Therapies and Comprehensive Wound Center, The Ohio State University , Wexner Medical Center, Columbus, Ohio, USA.
Sashwati Roy1 Department of Surgery, Davis Heart and Lung Research Institute, Center for Regenerative Medicine and Cell-Based Therapies and Comprehensive Wound Center, The Ohio State University , Wexner Medical Center, Columbus, Ohio, USA.
The Ohio State University Wexner Medical Center · USUnited Nations Development Programme · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe objective of the present study ( clinicaltrials.gov NCT02026414) was to observe the effects of oral supplementation of a purified and standardized Shilajit extract on skeletal muscle adaptation in adult overweight/class I obese human subjects from the U.S. POPULATION: Shilajit is a mineral pitch that oozes out of Himalayan rocks. The study design consisted of a baseline visit, followed by 8 weeks of 250 mg of oral Shilajit supplementation b.i.d., and additional 4 weeks of supplementation with exercise. At each visit, blood samples and muscle biopsies were collected for further analysis. Supplementation was well tolerated without any changes in blood glucose levels and lipid profile after 8 weeks of oral supplementation and the additional 4 weeks of oral supplementation with exercise. In addition, no changes were noted in creatine kinase and serum myoglobin levels after 8 weeks of oral supplementation and the additional 4 weeks of supplementation with exercise. Microarray analysis identified a cluster of 17 extracellular matrix (ECM)-related probe sets that were significantly upregulated in muscles following 8 weeks of oral supplementation compared with the expression at the baseline visit. This cluster included tenascin XB, decorin, myoferlin, collagen, elastin, fibrillin 1, and fibronectin 1. The differential expression of these genes was confirmed using quantitative real-time polymerase chain reaction (RT-PCR). The study provided maiden evidence that oral Shilajit supplementation in adult overweight/class I obese human subjects promoted skeletal muscle adaptation through upregulation of ECM-related genes that control muscle mechanotransduction properties, elasticity, repair, and regeneration.

Indexed as

Adaptation, PhysiologicalAdultDietary SupplementsExerciseExtracellular Matrix ProteinsFemaleHumansMaleMechanotransduction, CellularMineralsMuscle, SkeletalObesityOverweightResins, PlantTranscriptomeUp-RegulationExtracellular Matrix ProteinsMineralsmumieResins, Plantadaptationextracellular matrixShilajitskeletal muscle

Identifiers

PMID27414521
PMCPMC4948208
OpenAlexW2501013323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.